טוען...
Clinical utility of serum biomarkers in Duchenne muscular dystrophy
Assessments of disease progression and response to therapies in Duchenne muscular dystrophy (DMD) patients remain challenging. Current DMD patient assessments include complex physical tests and invasive procedures such as muscle biopsies, which are not suitable for young children. Defining alternati...
שמור ב:
| הוצא לאור ב: | Clin Proteomics |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4820909/ https://ncbi.nlm.nih.gov/pubmed/27051355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-016-9109-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|